These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1099 related items for PubMed ID: 25315243

  • 41. Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias.
    Karfis I, Marin G, Levillain H, Drisis S, Muteganya R, Critchi G, Taraji-Schiltz L, Guix CA, Shaza L, Elbachiri M, Mans L, Machiels G, Hendlisz A, Flamen P.
    Oncotarget; 2020 Feb 11; 11(6):589-599. PubMed ID: 32110279
    [Abstract] [Full Text] [Related]

  • 42. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C.
    J Nucl Med; 2011 Dec 11; 52(12):1864-70. PubMed ID: 22072704
    [Abstract] [Full Text] [Related]

  • 43. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
    Abdulrezzak U, Kurt YK, Kula M, Tutus A.
    Nucl Med Commun; 2016 Aug 11; 37(8):874-81. PubMed ID: 27096719
    [Abstract] [Full Text] [Related]

  • 44. Prospective evaluation of 68Ga-DOTA-NOC PET-CT in patients with recurrent medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
    Naswa N, Sharma P, Suman Kc S, Lata S, Kumar R, Malhotra A, Bal C.
    Nucl Med Commun; 2012 Jul 11; 33(7):766-74. PubMed ID: 22531829
    [Abstract] [Full Text] [Related]

  • 45. Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.
    Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A.
    Clin Nucl Med; 2015 Jan 11; 40(1):e6-e10. PubMed ID: 24999675
    [Abstract] [Full Text] [Related]

  • 46. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
    Armbruster M, Zech CJ, Sourbron S, Ceelen F, Auernhammer CJ, Rist C, Haug A, Singnurkar A, Reiser MF, Sommer WH.
    J Magn Reson Imaging; 2014 Aug 11; 40(2):457-66. PubMed ID: 24347148
    [Abstract] [Full Text] [Related]

  • 47. Gallium-68 Dotatate PET/CT is superior to other imaging modalities in the detection of medullary carcinoma of the thyroid in the presence of high serum calcitonin.
    Tran K, Khan S, Taghizadehasl M, Palazzo F, Frilling A, Todd JF, Al-Nahhas A.
    Hell J Nucl Med; 2015 Aug 11; 18(1):19-24. PubMed ID: 25679074
    [Abstract] [Full Text] [Related]

  • 48. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma.
    Conry BG, Papathanasiou ND, Prakash V, Kayani I, Caplin M, Mahmood S, Bomanji JB.
    Eur J Nucl Med Mol Imaging; 2010 Jan 11; 37(1):49-57. PubMed ID: 19662413
    [Abstract] [Full Text] [Related]

  • 49. (68)Ga-DOTATATE PET/CT in the evaluation of patients with neuroendocrine metastatic carcinoma of unknown origin.
    Alonso O, Rodríguez-Taroco M, Savio E, Bentancourt C, Gambini JP, Engler H.
    Ann Nucl Med; 2014 Aug 11; 28(7):638-45. PubMed ID: 24862238
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.
    Haug AR, Cindea-Drimus R, Auernhammer CJ, Reincke M, Wängler B, Uebleis C, Schmidt GP, Göke B, Bartenstein P, Hacker M.
    J Nucl Med; 2012 Nov 11; 53(11):1686-92. PubMed ID: 22984220
    [Abstract] [Full Text] [Related]

  • 52. Defining the optimal segmentation method for measuring somatostatin receptor expressing tumor volume on 68 Ga-DOTATATE positron emission tomography/computed tomography to predict prognosis in patients with gastroenteropancreatic neuroendocrine tumors.
    Filizoglu N, Ozguven S, Akin Telli T, Ones T, Dede F, Turoglu HT, Erdil TY.
    Nucl Med Commun; 2024 Aug 01; 45(8):736-744. PubMed ID: 38745508
    [Abstract] [Full Text] [Related]

  • 53. [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer.
    Vrachimis A, Stegger L, Wenning C, Noto B, Burg MC, Konnert JR, Allkemper T, Heindel W, Riemann B, Schäfers M, Weckesser M.
    Eur J Nucl Med Mol Imaging; 2016 Sep 01; 43(10):1765-72. PubMed ID: 27059853
    [Abstract] [Full Text] [Related]

  • 54. 68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
    Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J, Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K.
    J Nucl Med; 2016 Feb 01; 57(2):186-91. PubMed ID: 26564322
    [Abstract] [Full Text] [Related]

  • 55. Clinical value of ⁶⁸Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET).
    Albanus DR, Apitzsch J, Erdem Z, Erdem O, Verburg FA, Behrendt FF, Mottaghy FM, Heinzel A.
    Eur J Radiol; 2015 Oct 01; 84(10):1866-72. PubMed ID: 26152870
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Optimizing Somatostatin Receptor Imaging in Patients With Neuroendocrine Tumors: The Impact of 99mTc-HYNICTOC SPECT/SPECT/CT Versus 68Ga-DOTATATE PET/CT Upon Clinical Management.
    Kunikowska J, Lewington V, Krolicki L.
    Clin Nucl Med; 2017 Dec 01; 42(12):905-911. PubMed ID: 29076910
    [Abstract] [Full Text] [Related]

  • 60. Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective.
    Herrmann K, Czernin J, Wolin EM, Gupta P, Barrio M, Gutierrez A, Schiepers C, Mosessian S, Phelps ME, Allen-Auerbach MS.
    J Nucl Med; 2015 Jan 01; 56(1):70-5. PubMed ID: 25500825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.